| 000 | 03023 a2200781 4500 | ||
|---|---|---|---|
| 005 | 20250514053914.0 | ||
| 264 | 0 | _c20030305 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 024 | 7 |
_a10.4049/jimmunol.170.1.508 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDobrovolskaia, Marina A | |
| 245 | 0 | 0 |
_aInduction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJan 2003 |
||
| 300 |
_a508-19 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDown-Regulation _xgenetics |
| 650 | 0 | 4 | _aDrosophila Proteins |
| 650 | 0 | 4 |
_aEnzyme Activation _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHost Cell Factor C1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aI-kappa B Kinase |
| 650 | 0 | 4 |
_aImmune Tolerance _xgenetics |
| 650 | 0 | 4 |
_aInterferon-beta _xantagonists & inhibitors |
| 650 | 0 | 4 | _aInterleukin-1 Receptor-Associated Kinases |
| 650 | 0 | 4 | _aJNK Mitogen-Activated Protein Kinases |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages, Peritoneal _xenzymology |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xagonists |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNF-kappa B p50 Subunit |
| 650 | 0 | 4 | _aOctamer Transcription Factor-1 |
| 650 | 0 | 4 | _aProtein Kinase Inhibitors |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xagonists |
| 650 | 0 | 4 | _aSequence Deletion |
| 650 | 0 | 4 |
_aSignal Transduction _xgenetics |
| 650 | 0 | 4 | _aToll-Like Receptor 2 |
| 650 | 0 | 4 | _aToll-Like Receptor 4 |
| 650 | 0 | 4 | _aToll-Like Receptors |
| 650 | 0 | 4 |
_aTrans-Activators _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 650 | 0 | 4 | _aTranscription Factor RelA |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aMedvedev, Andrei E | |
| 700 | 1 | _aThomas, Karen E | |
| 700 | 1 | _aCuesta, Natalia | |
| 700 | 1 | _aToshchakov, Vladimir | |
| 700 | 1 | _aRen, Tianbo | |
| 700 | 1 | _aCody, Michael J | |
| 700 | 1 | _aMichalek, Suzanne M | |
| 700 | 1 | _aRice, Nancy R | |
| 700 | 1 | _aVogel, Stefanie N | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 170 _gno. 1 _gp. 508-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.170.1.508 _zAvailable from publisher's website |
| 999 |
_c12300353 _d12300353 |
||